Fox Foundation offers $2m for ‘game-changing’ Parkinson’s breakthrough

PD in Practice

Author: Parkinson's Life editorsPublished: 7 July 2016

Prep: Cook: Serves:

The Michael J Fox Foundation is offering US$2 million to the first researcher to develop a tracer for alpha-synuclein – the protein that is a strong pathological indicator of Parkinson’s disease.

Imaging of alpha-synuclein could become a useful biomarker of the presence of the disease and possibly even a measure of disease progression.

In a statement issued on its website, the Foundation said: “The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson’s disease field.

“With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.”

The prize is open to all academic and industry researchers and contestants may already be funded by the MJFF or not. There is no deadline and the $2 million prize will be awarded to the first contestant who submits “compelling evidence of a viable selective tracer and agrees to its widespread use”.

To see the full submission requirements, the judging panel and how to apply, visit the website here

Learn more about alpha-synuclein in this free podcast: ‘Stopping disease progression’

Last Month

Next Month

Go Back

Share this story

Comments

Special reports

Parkinson’s and depression: It’s not all in your mind

Depression may be common among PwPs, but it's not a sign of weakness

UK Prime Minister hosts reception to mark 200 years since the discovery of Parkinson’s

Theresa May pledges millions to neurological research projects

6 more world-class wildlife stills from a photographer with Parkinson’s

David Plummer shares more of his top photographs of wildlife in action

World War II weapon antidote could treat Parkinson’s

Researchers at Purdue University, US, are studying a World War II chemical weapon antidote that they believe could be used to treat Parkinson’s. It is believed the antidote, called dimercaprol, may be able to remove acrolein – a toxin that poisons neurons and can lead to the development of Parkinson’s disease. In addition to this, researchers believe dimercaprol can increase the survival rate of brain cells, improve mobility and reduce symptoms of pain. Riyi Shi, professor of neuroscience and biomedical engineering at Purdue University, said: “Our studies show that by removing the toxin (acrolein) from the brain, we are not just reducing the symptoms of Parkinson’s disease but also significantly reversing the damage of Parkinson’s disease. This could actually provide a new treatment for Parkinson’s patients.”

Repurposed cancer drug shows promise for Parkinson’s

Researchers at the Oxford Parkinson’s Disease Centre, UK, have repurposed an experimental cancer drug – called tasquinimod – as a potential treatment for Parkinson’s. The study – funded by Parkinson’s UK and published in science journal ‘Cell Stem Cell’ – has been tested on a total of 10 patients so far. As part of the research, the study grew brain cells from donated skin cell samples of people living with a rare genetic form of Parkinson’s – this process was then repeated on people with a common non-genetic form of the condition. Researchers found that tasquinimod can block HDAC4, a protein that causes Parkinson’s genes to become inactive. Professor Richard Wade-Martins, co-lead author of the study, said: “We think that switching off these genes in brain cells may play a vital role in the cell damage and death that occurs in Parkinson’s.”

Research survey assesses impact of holidays on Parkinson’s symptoms

The Radboud University Medical Center, Netherlands, is seeking participants for an online survey assessing the effects of a holiday on Parkinson’s. The study will assess whether a vacation can have physical and mental benefits for people living with the condition. It will also look at which specific factors, such as temperature and physical activity, can alleviate or increase symptoms. The Michael J Fox Foundation has approved the study’s protocol. Participants can sign up to complete the 20-minute survey online. The survey is open to anyone over 18 who has Parkinson’s and has been on vacation once or more between 1 June 2016 and 30 September 2018. Marjan Faber, the study’s daily supervisor, said: “If the study is able to identify decisive factors, those can act as a starting point for novel approaches in care for people with Parkinson’s disease.” To apply please visit research platform ParkinsonNEXT.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Fox Foundation offers $2m for ‘game-changing’ Parkinson’s breakthrough

PD in Practice

Author: Parkinson's Life editorsPublished: 7 July 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Special reports

Parkinson’s and depression: It’s not all in your mind

Europe

UK Prime Minister hosts reception to mark 200 years since the discovery of Parkinson’s

Perspectives

6 more world-class wildlife stills from a photographer with Parkinson’s

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Fox Foundation offers $2m for ‘game-changing’ Parkinson’s breakthrough

PD in Practice

Author: Parkinson's Life editorsPublished: 7 July 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Special reports

Parkinson’s and depression: It’s not all in your mind

Europe

UK Prime Minister hosts reception to mark 200 years since the discovery of Parkinson’s

Perspectives

6 more world-class wildlife stills from a photographer with Parkinson’s

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Sign in